DiSTect: a Bayesian model for disease-associated gene discovery and prediction in spatial transcriptomics

Identifying disease-indicative genes is critical for deciphering disease mechanisms and continues to attract significant interest. Spatial transcriptomics offers unprecedented insights for the detection of disease-specific genes by enabling within-tissue contrasts. However, this new technology poses challenges for conventional statistical models developed for RNA-seq, as these models often neglect the spatial organization of tissue spots. In this article, we propose a Bayesian shrinkage model to characterize the relationship between high-dimensional gene expressions and the disease status of tissue spots, incorporating spatial correlation among these spots through autoregressive terms. Our model adopts a hierarchical structure to accommodate for the missing data within tissues and is further extended to facilitate the analysis of multiple correlated samples. To ensure the model’s applicability to datasets of varying sizes, we carry out two computational frameworks for Bayesian parameter estimation, tailored to both small and large sample scenarios.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-09-15
DOI
https://doi.org/10.5281/zenodo.17127210
Primary Topic
Geochemistry and Geologic Mapping
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

DiSTect: a Bayesian model for disease-associated gene discovery and prediction in spatial transcriptomics

Zenodo (CERN European Organization for Nuclear Research)
Geochemistry and Geologic Mapping
article

DiSTect: a Bayesian model for disease-associated gene discovery and prediction in spatial transcriptomics

article en

Abstract

Identifying disease-indicative genes is critical for deciphering disease mechanisms and continues to attract significant interest. Spatial transcriptomics offers unprecedented insights for the detection of disease-specific genes by enabling within-tissue contrasts. However, this new technology poses challenges for conventional statistical models developed for RNA-seq, as these models often neglect the spatial organization of tissue spots. In this article, we propose a Bayesian shrinkage model to characterize the relationship between high-dimensional gene expressions and the disease status of tissue spots, incorporating spatial correlation among these spots through autoregressive terms. Our model adopts a hierarchical structure to accommodate for the missing data within tissues and is further extended to facilitate the analysis of multiple correlated samples. To ensure the model’s applicability to datasets of varying sizes, we carry out two computational frameworks for Bayesian parameter estimation, tailored to both small and large sample scenarios.

Zenodo (CERN European Organization for Nuclear Research)
McGill University (CA)
Openalex Percentile: Top 43%
Geochemistry and Geologic Mapping
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

DiSTect: a Bayesian model for disease-associated gene discovery and prediction in spatial transcriptomics · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS